Engineering Extracellular Vesicles for Osteoarthritis Treatment: From Therapeutic Strategies-to-Clinical Translation
en-GBde-DEes-ESfr-FR

Engineering Extracellular Vesicles for Osteoarthritis Treatment: From Therapeutic Strategies-to-Clinical Translation

04/02/2026 Compuscript Ltd

https://www.scienceopen.com/hosted-document?doi=10.15212/bioi-2025-0177
Announcing a new article publication for BIO Integration journal. Extracellular vesicles (EVs) are membrane-bound nanoparticles secreted by cells and have emerged as promising therapeutic agents for osteoarthritis (OA). These vesicles exhibit high biocompatibility and the intrinsic ability to traverse physiologic barriers, delivering bioactive molecular cargo to recipient cells to exert regulatory effects. To enhance therapeutic efficacy, EVs can be bioengineered to improve biological activity and targeting capacity toward specific cells or tissues. Strategies for EV engineering primarily involve modifications to cargo, membranes, or the pretreatment of parental cells. In recent years advances in EV engineering have led to growing interest in the application of engineered EVs for OA treatment, offering new possibilities for clinical translation. This review summarizes the fundamental characteristics of EVs and examine the factors limiting the current therapeutic efficacy in OA. An overview of existing engineering strategies and a discussion of the therapeutic applications of engineered EVs in OA models is also provided. Finally the remaining challenges and future directions necessary to advance EV-based therapies toward clinical use in OA are outlined.
# # # # # #
BIO Integration is fully open access journal which will allow for the rapid dissemination of multidisciplinary views driving the progress of modern medicine.

As part of its mandate to help bring interesting work and knowledge from around the world to a wider audience, BIOI will actively support authors through open access publishing and through waiving author fees in its first years. Also, publication support for authors whose first language is not English will be offered in areas such as manuscript development, English language editing and artwork assistance.

Please visit www.bio-integration.org to learn more about the journal.
Editorial Board: https://bio-integration.org/editorial-board/

BIOI is available on the ScienceOpen platform (https://www.scienceopen.com/search#collection/55f45bac-fd64-431c-9fe7-50fd6a7f8781).

Submissions may be made using ScholarOne (https://mc04.manuscriptcentral.com/bioi).
There are no author submission or article processing fees.

Follow BIOI on Twitter @JournalBio; Facebook (https://www.facebook.com/BIO-Integration-Journal-108140854107716/) and LinkedIn (https://www.linkedin.com/company/bio-integration-journal/).

ISSN 2712-0074
eISSN 2712-0082

Jiashuo Liu, Lei Luo and Kai Feng et al. Engineering Extracellular Vesicles for Osteoarthritis Treatment: From Therapeutic Strategies-to-Clinical Translation. BIOI. 2026. Vol. 7(1). DOI: 10.15212/bioi-2025-0177
# # # # # #
Jiashuo Liu, Lei Luo and Kai Feng et al. Engineering Extracellular Vesicles for Osteoarthritis Treatment: From Therapeutic Strategies-to-Clinical Translation. BIOI. 2026. Vol. 7(1). DOI: 10.15212/bioi-2025-0177
04/02/2026 Compuscript Ltd
Regions: Europe, Ireland
Keywords: Health, Medical

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...


  • e
  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by AlphaGalileo Terms Of Use Privacy Statement